Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

143.93
Delayed Data
As of Oct 20
 +0.58 / +0.40%
Today’s Change
87.50
Today|||52-Week Range
144.86
+41.65%
Year-to-Date

Today’s Trading

Previous close143.35
Today’s open143.89
Day’s range142.83 - 144.86
Volume132,753
Average volume (3 months)238,827
Market cap$3.0B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+37.40%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+51.53%
P/E ratio378.8
Price/Sales19.42
Price/Book8.82

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...-1.77-1.62%
PBHPrestige Brands Hold...+0.11+0.23%
MDCOMedicines Co-0.47-1.36%
ICPTIntercept Pharmaceut...-0.01-0.01%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)$0.61
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts